Clinical trial · Observational
Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China
An Observational Study of Patients With Newly Diagnosed Unresectable Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) in China
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this observational study is to describe patient and disease characteristics as well as treatment patterns in Chinese patients with unresectable stage IIIB or IV non-small cell lung cancer (NSCLC). In addition, this study characterizes the clinical outcomes for various populations of patients defined by clinical and tumor characteristics, treatment patterns, and hospital category defined by city tier and geographic region.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-Small Cell Lung Cancer, Lung Cancer, Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (6)
- label
- Tier 1 and North
- description
- Site as described by tier level of the city where the site is located and by geographical location: Tier 1 city in northern region of China
- interventionNames
- Other: No intervention
- label
- Tier 1 and South
- description
- Site as described by tier level of the city where the site is located and by geographical location: Tier 1 city in southern region of China
- interventionNames
- Other: No intervention
- label
- Tier 2 and Middle
- description
- Site as described by tier level of the city where the site is located and by geographical location: Tier city in middle region of China
- interventionNames
- Other: No intervention
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Histologically/cytologically confirmed, unresectable Stage IIIB or IV non-small cell lung cancer (NSCLC) * Received at least one anti-cancer treatment targeting unresectable Stage IIIB or IV NSCLC in the study site after study initiation * Radiographic evidence of disease Exclusion Criteria: * Prior systematic treatment for unresectable Stage IIIB or IV non-small cell lung cancer (NSCLC) * Participation in any anti-cancer, regimen-specified clinical study of first-line treatment for unresectable Stage IIIB or IV NSCLC.
References
Publications (0)
Data not yet available